Meet Our Team
Please meet the people behind our science, led by Tom Wiggans, with additional industry veterans from Connetics, Peplin, QLT and Gilead.Meet Our Management Team→
Technology Spotlight
Our lead product candidate is lemuteporfin (LTS), a potent and selective topical photodynamic therapy for sebaceous gland disorders, including acne.Dermira News
Dermira Announces a $42m Series A Financing to Fund Therapeutic Advances in Dermatology
Read Our Latest Press Release→
Dermira is a development-stage, private biotech company focused on developing and commercializing innovative new therapies in dermatology. Dermira was founded by an experienced management team and owns and licenses a robust pipeline of innovative topical compounds addressing areas of need in dermatology. Our lead product candidate, lemuteporfin (LTS), is currently in clinical trials for acne.